Response to the letter to the editor on "an indirect treatment comparison of the efficacy of patisiran and tafamidis for the treatment of hereditary transthyretin-mediated amyloidosis with polyneuropathy"

被引：0
|
作者：
Lin, Hollis [1 ]
Agarwal, Sonalee [1 ]
Betts, Marissa [2 ]
Fahrbach, Kyle [2 ]
Chitnis, Madhura [2 ]
Polydefkis, Michael [3 ]
机构：
[1] Alnylam Pharmaceut, Cambridge, MA USA
[2] Evidera, Waltham, MA USA
[3] Johns Hopkins Univ, Dept Neurol, Baltimore, MD 21218 USA
来源：
EXPERT OPINION ON PHARMACOTHERAPY | 2019年 / 20卷 / 12期
关键词：
Transthyretin amyloid polyneuropathy; indirect treatment comparison;
D O I：
10.1080/14656566.2019.1620987
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：1529 / 1530
页数：2
相关论文
共 50 条
  • [21] A Review of Patisiran (ONPATTRO®) for the Treatment of Polyneuropathy in People with Hereditary Transthyretin Amyloidosis
    Ivan Urits
    Daniel Swanson
    Michael C. Swett
    Anjana Patel
    Kevin Berardino
    Ariunzaya Amgalan
    Amnon A. Berger
    Hisham Kassem
    Alan D. Kaye
    Omar Viswanath
    Neurology and Therapy, 2020, 9 : 301 - 315
  • [22] Vutrisiran: A Review in Polyneuropathy of Hereditary Transthyretin-Mediated Amyloidosis
    Nie, Tina
    Heo, Young-A
    Shirley, Matt
    DRUGS, 2023, 83 (15) : 1425 - 1432
  • [23] A Review of Patisiran (ONPATTRO®) for the Treatment of Polyneuropathy in People with Hereditary Transthyretin Amyloidosis
    Urits, Ivan
    Swanson, Daniel
    Swett, Michael C.
    Patel, Anjana
    Berardino, Kevin
    Amgalan, Ariunzaya
    Berger, Amnon A.
    Kassem, Hisham
    Kaye, Alan
    Viswanath, Omar
    NEUROLOGY AND THERAPY, 2020, 9 (02) : 301 - 315
  • [24] Vutrisiran: A Review in Polyneuropathy of Hereditary Transthyretin-Mediated Amyloidosis
    Tina Nie
    Young-A Heo
    Matt Shirley
    Drugs, 2023, 83 : 1425 - 1432
  • [25] LONG-TERM, INTEGRATED CARDIAC SAFETY OF PATISIRAN IN PATIENTS WITH HEREDITARY TRANSTHYRETIN-MEDIATED AMYLOIDOSIS WITH POLYNEUROPATHY
    Dispenzieri, Angela
    Gillmore, Julian
    Polydefkis, Michael
    Plante-Bordeneuve, Violaine
    Schmidt, Hartmut
    Berber, Erhan
    Wang, Jing Jing
    Sweetser, Marianne
    White, Matthew
    Maurer, Mathew
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2020, 75 (11) : 690 - 690
  • [26] Impact of baseline neuropathy stage in patients with hereditary transthyretin-mediated (hATTR) amyloidosis with or without patisiran treatment
    Kyriakides, T.
    Brannagan, T.
    Lin, H.
    Wang, Y.
    Conceicao, I.
    EUROPEAN JOURNAL OF NEUROLOGY, 2019, 26 : 190 - 190
  • [27] Correction to: A Review of Patisiran (ONPATTRO®) for the Treatment of Polyneuropathy in People with Hereditary Transthyretin Amyloidosis
    Ivan Urits
    Daniel Swanson
    Michael C. Swett
    Anjana Patel
    Kevin Berardino
    Ariunzaya Amgalan
    Amnon A. Berger
    Hisham Kassem
    Alan D. Kaye
    Omar Viswanath
    Neurology and Therapy, 2021, 10 : 407 - 407
  • [28] LONGTERM TREATMENT EFFECTS OF INOTERSEN ON QUALITY OF LIFE IN PATIENTS WITH HEREDITARY TRANSTHYRETIN-MEDIATED AMYLOIDOSIS WITH POLYNEUROPATHY
    Brown, Duncan
    Karam, Chafic
    Yang, Min
    Done, Nicolae
    Zhu, JingJing
    Greatsinger, Ali
    Bozas, Ana
    Llonch, Montserrat Vera
    Signorovitch, James
    MUSCLE & NERVE, 2021, 64 : S57 - S57
  • [29] Effect of RNAi therapeutics patisiran and vutrisiran on orthostatic hypotension due to dysautonomia in patients with hereditary transthyretin-mediated amyloidosis with polyneuropathy
    Slama, M.
    Obici, L.
    Okumura, T.
    Arum, S.
    Hale, C.
    Jay, P. Y.
    Capocelli, K.
    Gonzalez-Duarte, A.
    EUROPEAN HEART JOURNAL, 2022, 43 : 2625 - 2625
  • [30] Impact of Patisiran, an RNAi Therapeutic, on Diarrhea Symptoms in Patients With Hereditary Transthyretin-Mediated Amyloidosis
    Obici, Laura
    Gonzalez-Duarte, Alejandra
    Waddington-Cruz, Marcia
    Lin, Hollis
    Merkel, Madeline
    Wang, Yue
    Ueda, Mitsuharu
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2020, 115 : S1657 - S1657
12345